Buck, Dorothea Andlauer, Till FM Igl, Wilmar Wicklein, Eva-Maria Mühlau, Mark Weber, Frank Köchert, Karl Pohl, Christoph Arnason, Barry Comi, Giancarlo Cook, Stuart Filippi, Massimo Hartung, Hans-Peter Jeffery, Douglas Kappos, Ludwig Barkhof, Frederik Edan, Gilles Freedman, Mark S Montalbán, Xavier Müller-Myhsok, Bertram Hemmer, Bernhard MSJ763089_supplement – Supplemental material for Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials <p>Supplemental material, MSJ763089_supplement for Effect of <i>HLA-DRB1</i> alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials by B Hemmer, Dorothea Buck, Mark Mühlau, Till FM Andlauer, Wilmar Igl, Eva-Maria Wicklein, Karl Köchert, Frank Weber, Christoph Pohl, Barry Arnason, Giancarlo Comi, Stuart Cook, Massimo Filippi, Hans-Peter Hartung, Douglas Jeffery, Ludwig Kappos, Frederik Barkhof, Gilles Edan, Mark S Freedman, Xavier Montalbán, Bertram Müller-Myhsok and Bernhard Hemmer in Multiple Sclerosis Journal</p> Multiple sclerosis;interferon beta;anti-drug antibodies;genetic variation;HLA-DRB1;genome-wide association study 2018-03-09
    https://sage.figshare.com/articles/journal_contribution/MSJ763089_supplement_Supplemental_material_for_Effect_of_i_HLA-DRB1_i_alleles_and_genetic_variants_on_the_development_of_neutralizing_antibodies_to_interferon_beta_in_the_BEYOND_and_BENEFIT_trials/6396683
10.25384/SAGE.6396683.v1